Corvus Pharmaceuticals, Inc. (CRVS)
15.85
-0.89
(-5.32%)
USD |
NASDAQ |
Apr 20, 14:29
Corvus Pharmaceuticals SG&A Expense (Quarterly) : 2.278M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 775.00M |
| Plus Therapeutics, Inc. | 4.168M |
| Geron Corp. | 41.67M |
| Nektar Therapeutics | 11.18M |
| Jaguar Health, Inc. | 7.164M |